Hirata J, Takatsuki H, Umemura T, Goto T, Sadamura S, Abe Y, Nishimura J, Sato H, Nawata H
Department of Clinical Laboratory, Kyushu University Hospital, Fukuoka, Japan.
Cancer Genet Cytogenet. 1993 Apr;66(2):103-7. doi: 10.1016/0165-4608(93)90236-f.
The 14q+ chromosomal anomaly commonly found in cases of lymphoid neoplasm recurrently occurred during the lymphoid crisis of a patient with Philadelphia chromosome (Ph) positive chronic myelogenous leukemia (CML). At presentation lymphoblasts, with pre-B phenotype increased, and both the Ph and 14q+ were found in the same metaphases. After treatment with vincristine and prednisolone, the patient entered into the chronic phase, and only a Ph was detected in 100% of the cells examined. The 14q+ reappeared at the recurrence of the lymphoid crisis, and then disappeared in the second chronic phase. The BCR/ABL mRNA, which is specific for CML, was detected in the blastic cells by a method using reverse transcriptase and polymerase chain reaction. The rearrangement of the immunoglobulin heavy chain gene (JH gene) was also detected in the blastic cells. These results suggest that the 14q+ was closely associated with the lymphoid crisis of the CML patient.
14号染色体长臂增加(14q+)这一常见于淋巴系统肿瘤病例中的染色体异常,在一名费城染色体(Ph)阳性慢性粒细胞白血病(CML)患者的淋巴细胞危象期间反复出现。初诊时,前B表型的淋巴母细胞增多,且在同一中期相中同时发现了Ph和14q+。在用长春新碱和泼尼松龙治疗后,患者进入慢性期,在所检测的100%细胞中仅检测到Ph。14q+在淋巴细胞危象复发时再次出现,然后在第二个慢性期消失。通过使用逆转录酶和聚合酶链反应的方法,在母细胞中检测到了CML特有的BCR/ABL mRNA。在母细胞中还检测到了免疫球蛋白重链基因(JH基因)的重排。这些结果表明,14q+与该CML患者的淋巴细胞危象密切相关。